Recombinant MS4A1 (Ofatumumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-MS4A1 (Ofatumumab Biosimilar) antibody has been validated for ELISA. It is suitable to detect MS4A1 (Ofatumumab Biosimilar) in samples from Human.
Catalog No. ABIN7487871
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant MS4A1 (Ofatumumab Biosimilar) antibody (ABIN7487871)
Target
MS4A1 (Ofatumumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This MS4A1 (Ofatumumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Ofatumumab Biosimilar - Anti-MS4A1, CD20 mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- MS4A1 (Ofatumumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
HuMax-CD20
Ofatumumab is a fully human monoclonal antibody against CD20 protein that appears to inhibit early-stage B lymphocyte activation. Ofatumumab binds specifically to both the small and large extracellular loops of the CD20 molecule which is expressed on normal B lymphocytes (pre-B- to mature B-lymphocyte) and on B-cell CLL. -
CAS-No
- 679818-59-8
Target
-
You are here:
